Literature DB >> 5230286

Clinical use of furosemide.

F C Reubi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5230286     DOI: 10.1111/j.1749-6632.1966.tb41217.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  14 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

Review 2.  Use of serum creatinine concentrations to determine renal function.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

3.  Effect of ethacrynic acid and furosemide on renal function in hypovolemia.

Authors:  A M Stone; W M Stahl
Journal:  Ann Surg       Date:  1971-07       Impact factor: 12.969

4.  Prophylactic diuresis with ethacrynic acid for prevention of postoperative renal failure.

Authors:  W M Stahl; A M Stone
Journal:  Ann Surg       Date:  1970-09       Impact factor: 12.969

5.  Frusemide in heart failure of infancy.

Authors:  H Richardson
Journal:  Arch Dis Child       Date:  1971-08       Impact factor: 3.791

6.  Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.

Authors:  C Marone; F C Reubi; W Lahn
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Comparison of the pharmacodynamic effect of muzolimine and furosemide in patients with advanced chronic renal insufficiency.

Authors:  P Schmidt; D Loew; J Dýcka; H Kopsa; P Balcke; J Zazgornik; E Deutsch
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

8.  Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man.

Authors:  I G Mackay; A L Muir; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

9.  Diuretic action of bumetanide in advanced chronic renal insufficiency.

Authors:  K J Berg; A Tromsdal; T E Wideroe
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

10.  Experiences with high doses of furosemide in renal disease and resistant edematous states.

Authors:  D S Silverberg; R A Ulan; M A Baltzan; R B Baltzan
Journal:  Can Med Assoc J       Date:  1970-07-18       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.